Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00311038
Recruitment Status : Completed
First Posted : April 5, 2006
Last Update Posted : June 13, 2012
Information provided by (Responsible Party):
Ono Pharmaceutical Co. Ltd

Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Condition or disease Intervention/treatment Phase
Coronary Artery Disease Drug: ONO-1101 Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice Computed Tomography (CT) Due to Suspected Coronary Artery Disease
Study Start Date : April 2006

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. heart rate
  2. image quality
  3. safety

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 74 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. 20-74 years old
  2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room

Exclusion Criteria:

  1. Previous allergic reactions to contrast agent
  2. Renal failure
  3. Asthma
  4. Other exclusion criteria as specified in the protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00311038

Hokuriku Region Facility
Hokuriku, Japan
Kanto Region Facility
Kanto, Japan
Kyusyu Region Facility
Kyusyu, Japan
Sponsors and Collaborators
Ono Pharmaceutical Co. Ltd
Study Director: Project Leaders Development Planning Ono Pharmaceutical Co. Ltd

Responsible Party: Ono Pharmaceutical Co. Ltd Identifier: NCT00311038     History of Changes
Other Study ID Numbers: ONO-1101-24
First Posted: April 5, 2006    Key Record Dates
Last Update Posted: June 13, 2012
Last Verified: June 2012

Keywords provided by Ono Pharmaceutical Co. Ltd:
Landiolol Hydrochloride
Multi-slice CT
Coronary Artery Disease

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases
Adrenergic beta-Antagonists
Adrenergic Antagonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Anti-Arrhythmia Agents